Abstract
A second antibody solid phase radioimmunoassay for measuring neuropeptide Y (NPY) in biological fluids is introduced. The sensitivity of the method allows also measurements of sub-normal levels of plasma serum NPY, necessary for obtaining further information of possible biological actions of circulating NPY. Characteristics of the NPY assay procedure are presented together with clinical experiments forced upon a possible renal dependence for NPY. Our data show that NPY at least partly is eliminated by the kidneys. Whether the highly increased NPY levels in patients with renal failure also are involved in the hypertensive mechanisms in these patient groups has to be further evaluated.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
